Melvin Feifer

Array ( [id] => 7395257 [patent_doc_number] => 20040018184 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-29 [patent_title] => 'Combined preparation for the treatment of neoplasic diseases or of infectious diseases' [patent_app_type] => new [patent_app_number] => 10/622727 [patent_app_country] => US [patent_app_date] => 2003-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4224 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0018/20040018184.pdf [firstpage_image] =>[orig_patent_app_number] => 10622727 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 133234 [patent_doc_number] => 07696306 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-04-13 [patent_title] => 'Compositions and methods for preventing or treating cancer' [patent_app_type] => utility [patent_app_number] => 10/618481 [patent_app_country] => US [patent_app_date] => 2003-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8949 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/696/07696306.pdf [firstpage_image] =>[orig_patent_app_number] => 10618481 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5219747 [patent_doc_number] => 20070161058 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-12 [patent_title] => 'Methods and compositions for diagnosing hepatocellular carcinoma' [patent_app_type] => utility [patent_app_number] => 10/520322 [patent_app_country] => US [patent_app_date] => 2003-07-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3289 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0161/20070161058.pdf [firstpage_image] =>[orig_patent_app_number] => 10520322 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7127264 [patent_doc_number] => 20050059008 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-17 [patent_title] => 'Compositions and methods for identifying and targeting cancer cells of alimentary canal origin' [patent_app_type] => utility [patent_app_number] => 10/611533 [patent_app_country] => US [patent_app_date] => 2003-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14323 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20050059008.pdf [firstpage_image] =>[orig_patent_app_number] => 10611533 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7449903 [patent_doc_number] => 20040010001 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-15 [patent_title] => 'Methods and compositions for modulating cell proliferation and cell death' [patent_app_type] => new [patent_app_number] => 10/464018 [patent_app_country] => US [patent_app_date] => 2003-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 44176 [patent_no_of_claims] => 77 [patent_no_of_ind_claims] => 43 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0010/20040010001.pdf [firstpage_image] =>[orig_patent_app_number] => 10464018 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6664028 [patent_doc_number] => 20030203354 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-30 [patent_title] => 'PGT and apoptosis' [patent_app_type] => new [patent_app_number] => 10/458185 [patent_app_country] => US [patent_app_date] => 2003-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7679 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20030203354.pdf [firstpage_image] =>[orig_patent_app_number] => 10458185 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7243635 [patent_doc_number] => 20050271669 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-08 [patent_title] => 'Combinations comprising epothilones and pharmaceutical uses thereof' [patent_app_type] => utility [patent_app_number] => 10/517074 [patent_app_country] => US [patent_app_date] => 2003-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7332 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0271/20050271669.pdf [firstpage_image] =>[orig_patent_app_number] => 10517074 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 356372 [patent_doc_number] => 07488809 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-02-10 [patent_title] => 'Chimeric polypeptide comprising the fragment B of shiga toxin and peptides of therapeutic interest' [patent_app_type] => utility [patent_app_number] => 10/443614 [patent_app_country] => US [patent_app_date] => 2003-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 6366 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/488/07488809.pdf [firstpage_image] =>[orig_patent_app_number] => 10443614 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7149437 [patent_doc_number] => 20040170989 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-02 [patent_title] => 'Cellular gene targets for controlling cell growth' [patent_app_type] => new [patent_app_number] => 10/441925 [patent_app_country] => US [patent_app_date] => 2003-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 9661 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0170/20040170989.pdf [firstpage_image] =>[orig_patent_app_number] => 10441925 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6977431 [patent_doc_number] => 20050287147 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-29 [patent_title] => 'Cancer-linked gene as target for chemotherapy' [patent_app_type] => utility [patent_app_number] => 10/514534 [patent_app_country] => US [patent_app_date] => 2003-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13040 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0287/20050287147.pdf [firstpage_image] =>[orig_patent_app_number] => 10514534 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7313121 [patent_doc_number] => 20040033520 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-19 [patent_title] => 'Compositions and methods for identifying and targeting cancer cells of alimentary canal origin' [patent_app_type] => new [patent_app_number] => 10/428225 [patent_app_country] => US [patent_app_date] => 2003-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26883 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0033/20040033520.pdf [firstpage_image] =>[orig_patent_app_number] => 10428225 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6710981 [patent_doc_number] => 20030170730 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-11 [patent_title] => 'Assay method, peptides and reagent kits for testing mrp-specific inhibitors' [patent_app_type] => new [patent_app_number] => 10/343013 [patent_app_country] => US [patent_app_date] => 2003-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 12857 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0170/20030170730.pdf [firstpage_image] =>[orig_patent_app_number] => 10343013 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5785171 [patent_doc_number] => 20060204957 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-14 [patent_title] => 'Mta1s, a steriod hormone receptor corepressor' [patent_app_type] => utility [patent_app_number] => 10/513423 [patent_app_country] => US [patent_app_date] => 2003-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 34736 [patent_no_of_claims] => 64 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0204/20060204957.pdf [firstpage_image] =>[orig_patent_app_number] => 10513423 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7406420 [patent_doc_number] => 20040024188 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-05 [patent_title] => 'Monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen' [patent_app_type] => new [patent_app_number] => 10/428360 [patent_app_country] => US [patent_app_date] => 2003-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 16132 [patent_no_of_claims] => 61 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0024/20040024188.pdf [firstpage_image] =>[orig_patent_app_number] => 10428360 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7117194 [patent_doc_number] => 20050070495 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-31 [patent_title] => 'Inhibition of DNA modulation caused by mutated p53' [patent_app_type] => utility [patent_app_number] => 10/890433 [patent_app_country] => US [patent_app_date] => 2003-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 1409 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0070/20050070495.pdf [firstpage_image] =>[orig_patent_app_number] => 10890433 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6805005 [patent_doc_number] => 20030232399 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-18 [patent_title] => 'Cancer detection methods and reagents' [patent_app_type] => new [patent_app_number] => 10/417633 [patent_app_country] => US [patent_app_date] => 2003-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 25013 [patent_no_of_claims] => 79 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0232/20030232399.pdf [firstpage_image] =>[orig_patent_app_number] => 10417633 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6701571 [patent_doc_number] => 20030224451 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-04 [patent_title] => 'Novel protein related to melanoma-inhibiting protein and uses thereof' [patent_app_type] => new [patent_app_number] => 10/409966 [patent_app_country] => US [patent_app_date] => 2003-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 41493 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 312 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0224/20030224451.pdf [firstpage_image] =>[orig_patent_app_number] => 10409966 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7463679 [patent_doc_number] => 20040053288 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-18 [patent_title] => 'Method for estimating therapeutic efficacy of tumor necrosis factor' [patent_app_type] => new [patent_app_number] => 10/409107 [patent_app_country] => US [patent_app_date] => 2003-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5176 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20040053288.pdf [firstpage_image] =>[orig_patent_app_number] => 10409107 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6711010 [patent_doc_number] => 20030170759 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-11 [patent_title] => 'Uses of antileukoprotease in carcinoma' [patent_app_type] => new [patent_app_number] => 10/408969 [patent_app_country] => US [patent_app_date] => 2003-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6678 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0170/20030170759.pdf [firstpage_image] =>[orig_patent_app_number] => 10408969 [rel_patent_id] =>[rel_patent_doc_number] =>)